John JJson Johnson
Pharma

Johnson & Johnson's Tecvayli struts its stuff as a monotherapy

In a multiple myeloma trial, Tecvayli cut the risk of disease progression or death by 71% over standard care in patients resistant to CD38 therapy.
FDA

FDA proposes flu shot labels include warnings for febrile seizures

Jan 15, 2026 12:07pm
John JJson Johnson

Johnson & Johnson's Tecvayli struts its stuff as a monotherapy

Brought to you by Cesars Entertainment
President Trump speaks in the Oval Office
Favicon Fierce Healthcare

Trump targets insurers, drug prices in 'Great Healthcare Plan'

Jan 15, 2026 11:51am
FDA

2025 approvals: Biopharma delivered 55 new drugs, biologics

Brought to you by Real Chemistry
BeOne Medicines Brukinsa TV ad

FDA chides BeOne, ImmunityBio in separate untitled letters

Jan 15, 2026 11:50am
More News

Astellas CEO resists 'rescue BD' as Xtandi patent cliff nears

Jan 15, 2026 10:42am

Hologic sets a screen to block cervical cancer with WNBA star

Jan 15, 2026 10:00am

JPM26, Day 3: AbbVie, AZ, Novo execs share visions for ’26

Jan 14, 2026 2:29pm
Fierce Biotech

JPM26: Sanofi looks ahead to lingering US policy hurdles

Jan 14, 2026 2:28pm